The Dodcast

Doddie wants to know why it's taken so long to make any major breakthroughs in the quest for a cure for MND and Professor of clinical neurology at the University of Oxford, Martin Turner, joins the former Scotland international and Jill Douglas to provide the answers and discuss some exciting new developments that are now on the horizon. Plus, the My Name'5 Doddie Foundation's medical strategy lead, Sean McGrath, discusses the work the foundation is doing to shake things up and looks at MND-SMART, a new multi-platform clinical trial in which multiple treatments are evaluated simultaneously. Supported by Aberdeen Standard Investments.

Jill and Doddie are joined by professor of clinical neurology at the University of Oxford, Martin Turner, and the My Name'5 Doddie Foundation's medical strategy lead, Sean McGrath, to discuss MND and living with the condition. We explore what Motor Neuron Disease is, how it affects people differently and possible reasons why people might develop it. Plus, Doddie tells us how he was told he wouldn't walk into the doctor's surgery in a year's time, talks about problems with the help on offer after diagnosis and shares suggestions on how to improve people's quality of life. Supported by Aberdeen Standard Investments.

Scottish rugby legend Doddie Weir brings you the first of his new podcast series The Dodcast. Together with host Jill Douglas and former Scotland international Kenny Logan, he discusses his career, being diagnosed with MND and living with the condition. He also opens up about the emotion of walking onto the Murrayfield turf with his sons ahead of Scotland's game against the All Blacks in November 2017 and shares some laughs from this Christmas party season! 

The Dodcast is coming soon...Jill Douglas presents a brand new podcast bringing together members of the sporting and medical worlds. She'll be talking to former Scotland international and British & Irish Lion Doddie Weir about his fight against motor neurone disease and to others both affected by the condition and working on new treatments in the battle against it.